- Estabilishment of Spidercore Incorporation(July, 2020)
- Signed MOU with "Kosin Hospital" and "Gilon Corp."(Clinical practice and validation smart healthcare solutions, Febuary, 2021)
- Selected as the Top 1000 Innovative Companies / Certified as Venture Company(May, 2021)
- Raised Seed Investment / Selected for an R&D Project(September, 2021)
- Signed MOU with "CHA University"(AI solution for drug development and side effect prediction, September, 2021)
- Joint Research Agreement with "Philopos Corp."(Smart screening system for on-site OCT devices, October, 2021)
- Signed MOU with bio-Corp. "B"(Discovery of new therapeutics candidates and development of new drugs, January, 2022)
- Discovery of 9 hits for IDO1 gene(August, 2022)
- Launched Fundus AI Solution at "Chaum Medical Check-up Center, Samsung Branch"(January, 2023)